ライフサイエンスコーパス: infinity

1 mptotic threshold at long durations (Delta L(infinity)).

2 ers (gamma), and limiting diffusion rates (d(infinity)).

3 ds ratio, 19.6; 95% confidence interval, 2.9-infinity).

4 ratio, 8.5; 95% confidence interval, 1.3 to infinity).

5 outcome from ketamine was 25 (95% CI, six to infinity).

6 cocaine concentration in brain, and the AUC2(infinity).

7 , SS, or SZ genotypes was 14.58 (95% CI 2.33-infinity).

8 fidence interval for half-life, 11 months to infinity).

9 when the system's carrying capacity tends to infinity).

10 (5; 95% CI, 3-9) than PCR-CI (27; 95% CI, 12-infinity).

11 ined; 95 percent confidence interval, 1.8 to infinity).

12 1.6-23), and Finland (MOR undefined; CI, 4.9-infinity).

13 ailure was -0.007 (1-sided 95% CI, -0.036 to infinity).

14 NH3)2PbI4 (n = 1) to 1.52 eV CH3NH3PbI3 (n = infinity).

15 tus (P < 0.05; OR, infinity; 95% CI, 0.76 to infinity).

16 divergent, almost everywhere either zero or infinity.

17 well as a positron component that escapes to infinity.

18 under selection and migration forces as t-->infinity.

19 lly with speed c(*) in the population as t-->infinity.

20 onal Naming Game corresponds to setting w at infinity.

21 reduction of the NPA, specified from optical infinity.

22 s the number of bases in each genome goes to infinity.

23 generally become unbounded as time tends to infinity.

24 the x-axis, represents all K values, zero to infinity.

25 the sense that Sigmainfinityn=1 dist(dn, X)<infinity.

26 radiation, which propagates toward quiescent infinity.

27 r operators with magnetic tensors growing at infinity.

28 perators with electric potentials growing at infinity.

29 , S(BG)(N) proportional, variant N for N --> infinity.

30 limiting cases of alpha --> 0 and alpha --> infinity.

31 pe fractionation only, leading to LambdaC/Br infinity.

32 in the limit as the number of demes tends to infinity.

33 s rapidly achieved by increasing alphaA/d to infinity.

34 s 100% as the seal/membrane ratio approaches infinity.

35 of viewing the equivalent target at optical infinity.

36 rease to unity as the temperature approaches infinity.

37 of traces on the ideal") is either 0, 1, or infinity.

38 unt correlates with the area under the curve infinity.

39 real function with a regular growth as x --> infinity.

40 of magnetic moment and charge 0 and lifetime infinity.

41 f 76% of the decay-corrected FDG activity at infinity.

42 e receptor had been instantaneously moved to infinity.

43 </= infinity, 1/p + 1/q = 1/r, and 2/3 < r < infinity.

44 c reference frames by placing visual cues at infinity.

45 ht V are perfectly transmitted even as V --> infinity.

46 onant scattering, when wavelength approaches infinity.

47 ency distributions ranging from alpha = 2 to infinity.

48 control subjects (OR = infinity [95% CI 1.2-infinity]).

49 olute risk 4.5%, relative risk infinity [1.7-infinity]).

50 ., S(q)(N) proportional, variant N for N --> infinity].

51 0(-4); odds ratio (OR) = 11.3, 95% CI = 3.7, infinity].

52 such that Lambda(T = 0) = 1 and Lambda(T --> infinity) = 0.

53 uted from size at age data were 4.48 m for L(infinity), 0.219 y(-1)for k, and -0.81 y for t(0).

54 raction (Cmax, 0.00; AUC0-96, 0.54; and AUC0-infinity, 0.36; P >/= .76).

55 is provided by critical scaling theory: X(T) infinity 1/(T - Tc)gamma, where gamma is a scaling expon

56 ss law for the magnetic susceptibility: X(T) infinity 1/(T - Weiss constant), where Weiss constant is

57 tions lead to the polymeric [[Ag(bptz)][PF6]]infinity (1) and the dinuclear compounds [Ag2(bptz)2(CH3

58 t(2)O yields [(Et(2)O)(3)Ln[Co(4)(CO)(11)]]( infinity ) (1, Ln = Yb; 2, Ln = Eu).

59 2)O)(3)(-)(x)()(THF)(x)()Ln[Co(4)(CO)(11)]]( infinity ) (1-3) possesses pseudo C(3)(v)() symmetry (an

60 2)O)(3)(-)(x)()(THF)(x)()Ln[Co(4)(CO)(11)]]( infinity ) (1-3; x = 0, 1) and [(THF)(5)Eu[Co(4)(CO)(11)

61 with IHPS (absolute risk 4.5%, relative risk infinity [1.7-infinity]).

62 th a positive likelihood ratio approximating infinity [1/0 (--> infinity)], and with a negative likel

63 n is expressed as [theta]lambda = fH[theta]H infinity(1-k/n) + f beta[theta]beta + ft[theta]t + fR[th

64 and reaction-limited (k(R)) rates, i.e., 1/k(infinity) = 1/k(D) + 1/k(R).

65 in which oxide ions in Sr(n+1)V(n)O(3n+1) (n=infinity, 1, 2) phases are topochemically replaced by hy

66 ned by maps Lp x Lq into Lr for 1 < p, q </= infinity, 1/p + 1/q = 1/r, and 2/3 < r < infinity.

67 n change in FEV1 was 7.0% (97.5% CI, 3.4% to infinity; 1-sided P < .001), and the between-group St Ge

68 of 14.6 m (Hodges-Lehmann 97.5% CI, 0.4 m to infinity; 1-sided P = .02).

69 n-group difference, 11.8% [97.5% CI, 1.0% to infinity]; 1-sided P = .01).

70 infinity) = 48 +/- 35 Pa for Jurkat cells, E(infinity) = 156 +/- 87 for neutrophils, mean +/- SD).

71 significantly with dose (rifapentine AUC(0- infinity): 296, 410, and 477 microg.hour/ml at 600, 900,

72 affords [(Et(2)O)(2)(THF)Yb[Co(4)(CO)(11)]]( infinity ) (3) and [(THF)(5)Eu[Co(4)(CO)(11)]]( infinity

73 he novel imidazolate metal-organic framework infinity(3)[Ba(Im)2] with divalent europium.

74 was (1-2 prescriptions, HR = 0 [95% CI, 0.00-infinity]; 30-39 prescriptions: HR = 3.23, 95% CI, 1.26-

75 rence in the bioavailability between NG (AUC infinity : 38.0 [range 20.1 to 48.5] microg x h/mL) and

76 to 48.5] microg x h/mL) and intravenous (AUC infinity : 39.5 [range 24.1 to 63.1] microg x h/mL, p =.

77 In contrast, [(THF)(5)Eu[Co(4)(CO)(11)]]( infinity ) (4) incorporates a C(2)(v)() symmetric cluste

78 ; x = 0, 1) and [(THF)(5)Eu[Co(4)(CO)(11)]]( infinity ) (4), were prepared and structurally character

79 inity ) (3) and [(THF)(5)Eu[Co(4)(CO)(11)]]( infinity ) (4).

80 riables: AUC0-96, 2.58; Cmax, 0.64; and AUC0-infinity, 4.05; P >/= .13) and that the 3 products were

81 infinity) = 855 +/- 670 Pa for HL60 cells, E(infinity) = 48 +/- 35 Pa for Jurkat cells, E(infinity) =

82 eak power-law dependence on pulling speed, f(infinity) = 60 pN(nu(pull)/microm/s)(0.25).

83 absolute difference, -3.7%; 95% CI, -9.1% to infinity); 78 patients (26.9%) in the high-flow group vs

84 and suicide deaths (OR, 15.62; 95% CI, 1.65-infinity [8 cases and 39 controls]).

85 er the plasma-concentration time curve [AUC0-infinity), 81.6+/-22.0 microg.min/mL; n=6) were not sign

86 stiffer than human neutrophils on average (E(infinity) = 855 +/- 670 Pa for HL60 cells, E(infinity) =

87 during labor (T(1/2), 87.3+/-24.7 min; AUC0-infinity, 88.1+/-16.6 microg.min/mL; n=6).

88 ts but were absent in control subjects (OR = infinity [95% CI 1.2-infinity]).

89 OR = 4.52, 95% CI: 2.00, 10.20) and E6 (OR = infinity, 95% CI: 4.64, infinity) of HPV16, as well as l

90 64), and cagA-positive status (P < 0.05; OR, infinity; 95% CI, 0.76 to infinity).

91 t 10q11.21q11.23: 5 [0.2%] vs 0 [0.03%]; OR, infinity; 95% CI, 1.26-infinity; corrected P = .71).

92 ree during year 2 of follow-up (odds ratio = infinity; 95% CI, 11.8 to infinity; P < .001).

93 the concentration-time curve from time 0 to infinity after single dosing (AUC(inf) ) and maximum obs

94 lfalfa sprout consumption ranged from 5.0 to infinity (all were statistically significant).

95 tio [OR] = infinity), and a restaurant (OR = infinity) (all P < .0001).

96 e plasma concentration vs. time curve (AUC(0-infinity)) among the groups were detected (p < 0.001), w

97 tric field dependence goes to 0 as r goes to infinity and 1/r goes to 0, the molecular shielding cons

98 These spacetimes are analytic about infinity and contain a dimensionless coupling constant M

99 nd m=3 for compound 2 (after 10 days), and n=infinity and m=5 for compound 3 (after 14 days).

100 As the number of size categories approaches infinity and the size distribution becomes continuous, t

101 ul toward a systematic approach to bypassing infinity and thus going beyond it in a broader range of

102 ies of K(B)aPP by extrapolating to [ATP4-] = infinity and to the absence of competing protons, and wa

103 ance, and -13.4 points (95% CI, -8 points to infinity) and -10.6 points (95% CI, -5.8 points to infin

104 ant (matched odds ratio, 4.6; 95% CI, 2.1 to infinity) and eating pico de gallo salsa (matched odds r

105 rebound was 0.107 (1-sided 95% CI, 0.028 to infinity) and for viral failure was -0.007 (1-sided 95%

106 tate activation and inactivation functions m(infinity) and h(infinity), as Boltzmann curves, defined

107 Experimental values of ST(m)/ST(m, infinity) and its dependence on /Z/ are in good agreemen

108 a (RR = 13.8), a pizzeria (odds ratio [OR] = infinity), and a restaurant (OR = infinity) (all P < .00

109 ihood ratio approximating infinity [1/0 (--> infinity)], and with a negative likelihood ratio equal t

110 L; sensitivity, 64%; specificity, 100%; PLR, infinity; and NPR, 0.36).

111 ul (positive likelihood ratio 213 [95% CI 13-infinity] and negative likelihood ratio 0.11 [0.04-0.32]

112 ental analysis (AUC from 0 to infinity [AUC0-infinity] and to the next dose [AUC0-tau]), and by indiv

113 g octahedral lead bromide chains [PbBr4 (2-)]infinity are surrounded by the organic cations C4N2H14 (

114 erns of different members (m = 0, 6, 12, 18, infinity) are consistent with pure phases crystallizing

115 In the 1D complexes ([Rh2(O2CCF3)4](L))infinity aromatic ligands serve as bidentate links betwe

116 a "Hall-insulator" phase in which rhoxx --> infinity as T --> 0 whereas rhoxy approaches a nonzero v

117 and inactivation functions m(infinity) and h(infinity), as Boltzmann curves, defined by half-activati

118 oarsenates have infinite single chains of (1/infinity)[AsQ(2)(-)] derived from corner-sharing pyramid

119 have polar structures built of different (1/infinity)[AsSe(2)(-)] chain conformations, whereas the d

120 75 mg/m2/d; the mean +/- SD C(max) and AUC(0-infinity) at 10 mg/m2/d were 776 +/- 459 nM and 1,355 +/

121 e very fast, i.e., red = ox + nETe(-) (kox = infinity) at the OE and ox + nETe(-) = red (kred = infin

122 ty) at the OE and ox + nETe(-) = red (kred = infinity) at the RE.

123 r laws that would diverge (that is, approach infinity) at ~225 K, so there may be a link between wate

124 he plasma concentration time curve from 0 to infinity (AUC(0-infinity)) of S-warfarin increased by 57

125 sma concentration-time curve extrapolated to infinity (AUC(0-infinity)) was 900 ng.h/mL, which is sim

126 asma concentration-time curve from time 0 to infinity (AUC(0-infinity)) were 162 +/- 155, 171 +/- 72,

127 ), non-compartmental analysis (AUC from 0 to infinity [AUC0-infinity] and to the next dose [AUC0-tau]

128 ordination network {[Fe(bbtr)(3)](BF(4))(2)}(infinity), bbtr = 1,4-di(1,2,3-triazol-1-yl)butane, the

129 are typically lower than in free solution (D infinity), because of a combination of hydrodynamic and

130 he field of view it looks, with an object at infinity being seen at the horizon.

131 tent with the interesting shear behavior and infinity bulk modulus of the same pattern.

132 d for bandgap tuning from E g = 1.60 eV (n = infinity; bulk) to 2.40 eV (n = 1).

133 en if the volume of the system tends towards infinity, but also provide a direct link between Manning

134 res characterized by their rate of growth at infinity, but if the growth is faster than a certain thr

135 y 4.6-fold and increased tacrolimus DN_AUC(0-infinity) by approximately 70-fold.

136 rine dose-normalized (DN) exposure (DN_AUC(0-infinity)) by approximately 4.6-fold and increased tacro

137 s, (ii) as z-score ranges from minus to plus infinity, calculating average scores can lead to canceli

138 The association rate constant (k(infinity)) can be decomposed into contributions from dif

139 - chain, whereas the analogous -(SeF4 -SeF4 )infinity - chain was found to have a number of imaginary

140 med the dynamic stability of the -(SF4 -SF4 )infinity - chain, whereas the analogous -(SeF4 -SeF4 )in

141 These chains in turn are separated by [Sr](infinity) chains.

142 ure (risk difference, 12.9%; 95% CI, 6.6% to infinity) [corrected].

143 MS) that uses an infrared microscope with an infinity-corrected reflective objective and a continuous

144 2%] vs 0 [0.03%]; OR, infinity; 95% CI, 1.26-infinity; corrected P = .71).

145 rized potentials than wild type (V(1/2) of s(infinity) curve approximately -130 mV vs. approximately

146 ete, and less voltage-dependent (V(1/2) of s(infinity) curve approximately -50 mV) than in wild type.

147 e benzocaine-induced leftward shift in the h(infinity) curve by up to 22 mV.

148 ized the g(V) curve but hyperpolarized the h(infinity) curve.

149 ensemble-state estimates explode to machine infinity, despite the true state remaining in a bounded

150 agents, and the association rate constant k(infinity) determined from both contributions has a quali

151 ve a focal length ranging from -infinity to +infinity (divergent and convergent), are also readily in

152 ion where the optical path length approaches infinity due to the Poynting vector lying nearly paralle

153 cle spacings that otherwise would diverge to infinity due to viscous disturbance flows.

154 precise interface control--from just the n = infinity end members (perovskites) to the entire RP homo

155 The functional form is D/D infinity = F(rs/k1/2) S(f), where f = [(rs+rf)/rf]2 phi

156 of a letter target for 5 minutes at optical infinity, followed by 3 minutes of viewing the target at

157 trained physicians, the likelihood ratio was infinity for an assessment of "malignant," 2.6 for "atyp

158 tion and area under the curve from time 0 to infinity for colchicine plus CYP3A4/P-glycoprotein inhib

159 ted in an invariant form; however, it gives +infinity for magnetic Schrodinger operators with magneti

160 brain abnormalities; and OR 24.7 (95% CI 2.9-infinity) for four cases without brain abnormalities.

161 all matched odds ratio was 73.1 (95% CI 13.0-infinity) for microcephaly and Zika virus infection afte

162 % CI, 4-37) for PFS and 119.5 mo (95% CI, 81-infinity) for OS (P < 10(-3)).

163 OS was 12 mo (3 mo to infinity) for patients with main PVT, versus 21.5 mo (12

164 zed patients versus 151 months (95% CI, 4 to infinity) for sensitized patients (P=0.5).

165 (95% CI 8.6-infinity); OR 113.3 (95% CI 14.5-infinity) for seven cases with brain abnormalities; and

166 ty) and -10.6 points (95% CI, -5.8 points to infinity) for St George's Respiratory Questionnaire (1-s

167 correlation between log t(c) and log Delta L(infinity) for the steady-pedestal paradigm (r = 0.72, P

168 and TeO6 polyhedra, which form a [TeMg3P2O14]infinity framework.

169 The magnitude of this factor ( infinity > alpha > 1) can be explained by a conformation

170 Theory predicts an axially symmetric (D(infinity h)) structure and a triplet electronic ground s

171 erpreted in terms of an axially symmetric (D(infinity h)) structure.

172 The C(2)(h)() symmetric form 1 and D(infinity)(h) form 5 were found to be the stable minima f

173 surface extends upwards from near (feet) to infinity (horizon).

174 tical and computational dynamic models reach infinity in finite time, extending analysis and numerics

175 levels of phospholamban, have increases in r infinity in response to the general anesthetics that res

176 rast, there were no significant changes in r infinity in response to the three general anesthetics.

177 n the presence of nZVI in anoxic conditions; infinity in the case of catalytic oxidation by H2O2 with

178 ately 1:1 in the SCN5A interdomain linker to infinity in the pore, transmembrane, and linker in KCNH2

179 (a limit such as the number of neurons N --> infinity, in which the fluctuations vanish) to the fluct

180 r the plasma concentration-time curve (AUC(0-infinity)) increased significantly with dose (rifapentin

181 mean-squared error M(rho;beta) = lim(M,N --> infinity)inf(lambda)sup(rank(X) </= rho . M)MSE(X,X(lamb

182 e hydroperoxide (CuOOH) concentration, but P infinity is independent of H2O2 concentration, indicatin

183 The reciprocal of P infinity is proportional to cumene hydroperoxide (CuOOH)

184 The reciprocal of P infinity is proportional to the reciprocal of the substr

185 with the same base composition (ST(m)/ST(m, infinity)) is independent of base composition but strong

186 As the lengths of compared sequences tend to infinity, it is also theoretically unknown whether the n

187 = 3 injury was 63 kph [39.1 mph (95% CI, 51-infinity kph)].

188 We prove that lim(n--> infinity )(log c(n)(Lambda)/((log n)(2)/log log n))=(3-2

189 tion stratification is 2.44 (95% CI 1.048 to infinity, Mantel-Haenszel test p=0.036).

190 easurable concentration, AUC extrapolated to infinity, maximum concentration [Cmax], and time to Cmax

191 tial Differential Equations, the crossing of infinity may persist for finite time, necessitating the

192 = 57.96, 95% confidence interval [CI]: 3.30-infinity, mean age no mutations = 50.35; p-value = 0.002

193 area under the concentration-time curve (AUC infinity ) measured by the trapezoidal method.

194 cked with SrH layers/chains, such that the n=infinity member, SrVO2H, can be considered to be analogo

195 mplete success and 30.3 months (95% CI, 19.0-infinity months) and 33.3 months (95% CI, 25.7-46.2 mont

196 months (95% confidence interval [CI], 15 to infinity months) with a 6-month PFS of 98% (95% CI, 94%

197 l [CI], 28.1-87.1) and 48.6 (95% CI, 25.5 to infinity) months, respectively (P = 0.828, log-rank test

198 1,..., bn) are arbitrary vectors in R(+)n=[0,infinity)n, and rho(mij) is the spectral radius of an n

199 itions on a(x) so that the sequence ([a(n)])(infinity)(n=1) is a good averaging sequence in L2 for th

200 At an MBP concentration extrapolated to infinity, no significant viscosity effect on k(cat)/K(m(

201 hat, we consider two new methods, adaptive L(infinity)-norm penalized NSC (ALP-NSC) and adaptive hier

202 fferential Equation examples the crossing of infinity occurs instantaneously.

203 sipeptide concentration-time curve from 0 to infinity of 2,414 ng/mL/h, similar to adults.

204 on-time area under the curve (AUC) from 0 to infinity of 239.6 ng/mL x h.

205 The [theta]H infinity of an infinite helix and its chain-length depen

206 octahedral one, and a systematic, countable infinity of icosahedral ones, one for each Goldberg tria

207 stinguish, remember and understand a virtual infinity of objects.

208 10.20) and E6 (OR = infinity, 95% CI: 4.64, infinity) of HPV16, as well as low CD4+ cell counts, whe

209 tration time curve from 0 to infinity (AUC(0-infinity)) of S-warfarin increased by 57% (90% CI, 32% t

210 and not linked with higher rifapentine AUC(0-infinity) or peak concentration.

211 not affect the area under the curve (AUC(0-->infinity)) or the half-lives of sulfadoxine or pyrimetha

212 of pathogenic (95% confidence interval: 4.0-infinity), or an odds ratio of 9.9 for a prediction of b

213 infection; crude overall OR 55.5 (95% CI 8.6-infinity); OR 113.3 (95% CI 14.5-infinity) for seven cas

214 to 4.0]), BVAB2 (risk ratio, 8.7 [CI, 2.5 to infinity]), or BVAB3 (risk ratio, 3.1 [CI, 1.7 to 5.8]);

215 , and extrapolating to the bulk limit (N --> infinity), our analysis supports the assignment of the "

216 D ratios, were 1.0 (referent), 1.3, 5.0, and infinity (P for trend < 0.0001).

217 tion curve compared with pdVWF-pdFVIII (AUC0-infinity) (P < .01).

218 care groups were +0.09 L (95% CI, 0.05 L to infinity) (P = .001) and +0.08 L (95% CI, 0.03 L to infi

219 y) (P = .001) and +0.08 L (95% CI, 0.03 L to infinity) (P = .002) for forced expiratory volume in the

220 in the first second, +21 m (95% CI, -4 m to infinity) (P = .06) and +21 m (95% CI, -5 m to infinity)

221 finity) (P = .06) and +21 m (95% CI, -5 m to infinity) (P = .12) for 6-minute walk distance, and -13.

222 between groups of -27.0% (95% CI, -31.6% to infinity) (P = .89).

223 ed 97.5% confidence interval [CI], (-7.90 to infinity); P = 0.0666; and 97.5% CI, (-8.51 to infinity)

224 finity); P = 0.0666; and 97.5% CI, (-8.51 to infinity); P = 0.1178; for combination regimens vs. mono

225 t the level of EBV DNA (OR > 10, 95% CI 2.53-infinity, P < 0.002).

226 dds ratio > 10, 95% confidence interval 2.53-infinity, P < 0.002).

227 previous EBV exposure (OR 9.35, 95% CI 1.45-infinity, P = 0.014).

228 8.8% difference (1-sided 97.5% CI, 0.009 to infinity; P < .001 for noninferiority).

229 w-up (odds ratio = infinity; 95% CI, 11.8 to infinity; P < .001).

230 ratio = 22.84; 95% confidence interval, 3.57-infinity; P < .001).

231 difference of 7.2% (1-sided 95% CI, -3.0% to infinity; P < .001).

232 -group difference, -0.14; 97.5% CI, -3.07 to infinity; P = .001 for noninferiority), meeting criteria

233 ty (difference, -3%; 1-sided 95% CI, -10% to infinity; P = .004 for noninferiority).

234 oup difference of 18% (1-sided 95% CI, 4% to infinity; P = .03).

235 ia (difference, -6%; 1-sided 95% CI, -20% to infinity; P = .14 for noninferiority).

236 n (26%) (difference, -1.6%; 95% CI, -0.15 to infinity; P = .66).

237 ore strongly with DQA1*0501 of the son (OR = infinity; p = 0.00002, pc = 0.0002).

238 difference, -5.3%; 1-sided 95% CI, -10.8% to infinity; P for noninferiority = .41).

239 diabetes from the father's side (odds ratio=infinity; P<0.001).

240 clophosphamide (odds ratio 110, 95% CI 14.04-infinity; p=0.00001).

241 een-group difference, 0.03 [95% CI, -0.07 to infinity], P < .001), meeting the prespecified margin of

242 MT group (difference, 4.7% [95% CI, -5.2% to infinity]; P < .001 for noninferiority).

243 difference of -0.3% [1-sided 95% CI, -4% to infinity]; P < .001 for noninferiority).

244 group (difference, -1.6% [95% CI, -10.5% to infinity]; P = .01 for noninferiority).

245 (risk difference of -7.0% [95% CI, -12.4% to infinity]; P = .38 for noninferiority).

246 parallel one-dimensional helical chains of 1/infinity[P2Se62-] which depict an oxidative polymerizati

247 pport vector machine with L(1) and joint L(1,infinity) penalties for binary and multiclass classifica

248 AA-related mortality and $7600 (CI, $3300 to infinity) per life-year gained based on all-cause death.

249 ligomer embedded in polymeric DNA (Deltan(u, infinity), per charge).

250 h a positive amyloid scan developed AD (OR = infinity; PPV = 86%, 95% CI = 72-95; NPV = 100%, 95% CI

251 ice, the wave nature of light resolves these infinities, producing interference patterns.

252 correlated with the standardised method AUC0-infinity (r(2)=0.74), but the latter correlated poorly w

253 We interpret these ST(m)/ST(m, infinity) ratios in terms of the ratio of thermodynamic

254 curve (AUC) value in brain (denoted by AUC2(infinity)) required to produce physiological effects has

255 ed to assign parameters X and [theta](lambda,infinity), required for rigorous calculation of FH value

256 e S0 and Sinfinity are [S] at time t = 0 and infinity, respectively, gives access to ki under any con

257 l limits ranged from 4.0 to 10.0, and 6.0 to infinity, respectively.

258 ecrease half-times of 62, 255, and 425 h and infinity, respectively.

259 tic metamaterials with Poisson ratio -1 and -infinity, respectively.

260 the penetration depth is predicted to go to infinity, resulting in zero mass, consistent with our me

261 s 5.25 (95% confidence interval (CI) 2.44 to infinity), similar to the previous estimates, but signif

262 red magnetic sublattices built of [FenSe4n+2]infinity single-chain edge-sharing octahedra, coherently

263 alysis of the dynamically stable -(SF4 -SF4 )infinity - structure revealed a multicenter character of

264 as [O(2)] --> 0 to 1.0 +/- 0.2 as [O(2)] --> infinity suggesting the dissociation rate constant from

265 benefit rises with the square of time (gain infinity t(1.94), R2=0.998, P<0.001).

266 All compounds contain the same parallel (1)/(infinity)[Ta(2)AsS(11)(3-)] polymeric anionic chains, bu

267 tly more total NER when extrapolating to t-->infinity than the other compounds studied.

268 f 119.5 mo (95% confidence interval [CI], 72-infinity), than for patients with a positive (18)F-FDG P

269 incide or asymptotically approach (for N --> infinity) the joint probabilities of the (N - 1)-system.

270 he product concentration at infinite time (P infinity), the apparent rate constant of P450 inactivati

271 Then, when r --> infinity, the asymptotic lower density of the sequence o

272 s--is exact when the spatial dimension d --> infinity, the evolution of systems properties with d may

273 Furthermore as n --> infinity, the trait values within a pedigree collectivel

274 ies associated with black holes and includes infinity, thereby avoiding the need to impose radiative

275 32 generations), estimates of Ne ranged from infinity to <0.1% of the true value (defined as Ne based

276 which can have a focal length ranging from -infinity to +infinity (divergent and convergent), are al

277 .22 to 0.52]; difference, -37 days [95% CI, -infinity to -19.5]), but there was no significant effect

278 6.7% vs 25.0%; difference, -8.3%; 97.5% CI, -infinity to -2.0%; P < .001 for inferiority and P = .006

279 naire score improved -8.9 points (97.5% CI, -infinity to -6.3 points; 1-sided P < .001), each favorin

280 The mutation shifted V(1/2)h( infinity ) to more negative membrane potentials and incr

281 ifted the steady-state inactivation curve (h infinity) toward the hyperpolarizing direction.

282 sual care (odds ratio, 1.8 [97.5% CI, 1.1 to infinity]; unadjusted between-group difference, 11.8% [9

283 ivariate stepwise regression analyses, AUC(0-infinity) values for rifapentine and the active 25-desac

284 ion (C(max)) and area under the curve (AUC(0-infinity)) values increased in a dose-proportionate mann

285 ver, dendritic growth and virtually relative infinity volume change during long-term cycling often le

286 The shift in h( infinity ) was the result of an increase in closed-state

287 48 vs 256 h; P<.001), and the median AUC(0-->infinity) was ~40% lower (22,816 vs 40,106 microg/mL/h,

288 n-time curve extrapolated to infinity (AUC(0-infinity)) was 900 ng.h/mL, which is similar to adults r

289 From NLPB values of Deltan(u)/Deltan(u, infinity), we predict Delta as a function of [salt] and

290 mit, in which the population size approaches infinity, we demonstrate that, when multiple loci are co

291 rease by one half) of 62, 255, and 425 h and infinity were used to simulate the dose rate patterns de

292 on-time curve from time 0 to infinity (AUC(0-infinity)) were 162 +/- 155, 171 +/- 72, 182 +/- 157, an

293 G (T4; OR = 5), and T3197C+A12308G (U5; OR = infinity), were all strongly associated with AMD.

294 malized feedback current, I(T)(L) = i(T)/i(T,infinity), where L = d/a and d is the distance traveled

295 h a recent exact replica computation for d = infinity, whereas some observations differ, as rationali

296 (>or=10%) difference between ST(m) and ST(m, infinity) which increases strongly with decreasing lengt

297 he limiting anisotropy at very long times (r infinity), which indicate increases in the fraction of o

298 otope slopes (Deltadelta13C/Deltadelta37Cl): infinity with PS, 0.33 +/- 0.04 for HY/DH and 1.5 +/- 0.

299 mations, it may become possible to go beyond infinity with the solution becoming again well behaved a

300 ool vary considerably among data sets at t-->infinity, with no clear dominance between (ii) and (iii)